hiv-specific cd8 cells
Cell therapyexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 1998 (NCT00110578)
Timeline
1990s
- Jan 1, 1998
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusImmunity, passive
Human immunodeficiency virus immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hiv-specific cd8 cells
- hiv-specific cd8+ t cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02563509 | Phase 1 | Jan 1, 2013 | Guangzhou University, Sun Yat-Sen University |
| NCT00110578 | Phase 1 | Sep 1, 1998 | National Institute of Allergy and Infectious Diseases (NIAID), University of Washington |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Guangzhou University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 1 | 1 | 1 | 1998 |
| Sun Yat-Sen University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| University of Washington | Academic/Hospital | 1 | 0 | 1 | 1998 |
4 organizations
Page 1 / 1